Everything we know about Mounjaro, new NHS weight loss jab

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
NICE has recommended Eli Lilly's obesity drug Mounjaro for around 220,000 people in the UK via the state health system over ...
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.
Ozempic (semaglutide) and Mounjaro (tirzepatide) are prescription drugs used to manage type 2 diabetes. They can also help with weight loss. Both drugs are injected once per week. Ozempic and ...
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...